Abstract
Many large pharmaceutical companies have a manufacturing base in Ireland. This
report is ideal for executives wanting to understand the key drivers in the
pharmaceutical market and have access to a wealth of statistical data,
including five-year market projections. Included with the report are 3 free
quarterly updated outlook reports, enabling you to keep up to date with market
developments for a year.
Includes 3 quarterly updated outlook reports!
Ireland is an island situated in the Atlantic Ocean, to the west of Great
Britain. The island is divided into 32 counties, 26 of which constitute the
Republic of Ireland. The remaining six counties constitute Northern Ireland,
which is part of the United Kingdom.
Ireland has a stable political situation, with the current president having
held office since 1997, after being re-appointed in 2004. After the
parliamentary election in 2007, the ruling coalition reconstituted their
partnership and solicited the support of the Green Party. A significant shift
in policy direction is not expected, apart from an increased emphasis on
environmental protection.
As a member state of the European Union, access to the pharmaceutical market
in Ireland is governed by EU regulations. Many large pharmaceutical companies
have a manufacturing base in Ireland as it is seen as a favourable
environment, in terms of an educated workforce and providing a
' stepping-stone' into the European Union.
Due to the presence of many multinationals in Ireland, the trade figures do
not give an accurate representation of the size of the pharmaceutical market.
This reflects Ireland' s role as a ' trading post' into Europe.
The pricing of pharmaceutical products in Ireland is based upon a currency
adjusted UK wholesale price and the average wholesale price of five EU
reference countries. Under the current scheme, prescribed drugs are available
free of charge to medical card holders and for persons suffering from
long-term illnesses, although sufferers of HIV/AIDS are not included.
View Cart
